Related Experiment Videos
Sensitization to DNA damage by okadaic acid or bromodeoxyuridine involves unequal effects on melanoma cell adhesion
1Instituto Venezolano de Investigaciones Cientificas (IVIC), Centre for Microbiology and Cell Biology, Caracas, Venezuela. mrieber@pasteur.ivic.ve
Abstract:
Because melanoma tumors originate partly from excessive UV exposure but become relatively resistant to radiation, we have now compared the effects of okadaic acid, a phosphatase inhibitor, with that of the thymidine analog bromodeoxyuridine as sensitizers of DNA damage in B16 melanoma. We now show that 25 nM okadaic acid promotes DNA fragmentation in B16 melanoma, increasing cell detachment as well as pigmentation, a characteristic of melanocytic cell differentiation. At lower levels, okadaic acid synergizes with UV exposure to increase DNA fragmentation. Although bromodeoxyuridine also caused DNA damage, it did not increase pigmentation and it suppressed cell detachment. Okadaic acid was also more effective in promoting DNA laddering in growing versus quiescent melanocytes. Because DNA damaging effects of okadaic acid are mediated by different pathways from those used by nucleoside analogs, like bromodeoxyuridine, we propose their concurrent effect with radiation as sensitizers to DNA damage.
Insights
Okadaic acid, a phosphatase inhibitor, enhances DNA damage in melanoma cells, increasing pigmentation and cell detachment. It synergizes with UV exposure, offering a potential radiosensitizer for melanoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Melanoma tumors exhibit resistance to radiation despite UV origin.
- Understanding DNA damage sensitization is crucial for melanoma therapy.
Purpose of the Study:
- To compare okadaic acid and bromodeoxyuridine as DNA damage sensitizers in B16 melanoma.
- To investigate their effects on DNA fragmentation, cell detachment, and pigmentation.
Main Methods:
- Treatment of B16 melanoma cells with okadaic acid and bromodeoxyuridine.
- Assessment of DNA fragmentation (DNA laddering), cell detachment, and pigmentation.
- Evaluation of drug synergy with UV exposure.
Main Results:
- Okadaic acid (25 nM) induced DNA fragmentation, increased pigmentation, and cell detachment in B16 melanoma.
- Okadaic acid synergized with UV exposure to enhance DNA fragmentation.
- Bromodeoxyuridine caused DNA damage but suppressed cell detachment and did not increase pigmentation.
- Okadaic acid was more effective in growing versus quiescent melanocytes.
Conclusions:
- Okadaic acid demonstrates potential as a radiosensitizer for melanoma by inducing DNA damage and promoting differentiation markers.
- The distinct mechanisms of okadaic acid and bromodeoxyuridine suggest combined therapeutic strategies with radiation.
- Further research into concurrent application of okadaic acid and radiation is warranted for melanoma treatment.